期刊文献+

血管生成素、基质金属蛋白酶-2在冠心病中的表达及相关性研究 被引量:9

The expression and correlation of angiopoietins and matrix metalloproteinase-2 in patients with coronary heart disease
暂未订购
导出
摘要 目的:探讨冠心病患者外周血血管生成素-1(Ang-1)、血管生成素-2(Ang-2)、基质金属蛋白酶-2(MMP-2)的表达及Ang-2与MMP-2水平的相关性。方法:选取冠心病患者126例,其中急性心肌梗死(AMI)42例,不稳定性心绞痛(UAP)42例,稳定性心绞痛(SAP)42例,同时选择45例体检健康者为对照组。应用Gensini积分法对冠心病病变血管狭窄程度进行定量评估,测定血浆Ang-1、Ang-2及MMP-2浓度,并对Ang-2和MMP-2水平进行相关性分析。结果:急性冠脉综合征组(AMI组和UAP组)血浆Ang-2和MMP-2水平均明显高于对照组和SAP组,差异具有统计学意义,而Ang-1在各组间无显著性差异。相关性分析显示冠心病组Gensini积分与Ang-2和MMP-2均呈明显的正相关,Ang-2与MMP-2水平呈显著的正相关。结论:Ang-2在急性冠脉综合征患者外周血中表达增加,可能系Ang-2促进MMP-2的表达引起斑块的稳定性降低而发挥作用。 Objective:To investigate the expression of angiopoietin-1 (Ang-1) ,angiopoietin-2 (Ang-2) and matrix metalloproteinase-2 (MMP-2) in patients with coronary heart disease and the correlation between Ang-2 and MMP-2 .Methods :126 patients with coronary heart disease were divided into three groups ,including 42 with a-cute myocardial infarction (AMI) ,42 with unstable angina pectoris (UAP) and 42 with stable angina pectoris (SAP) .Another 45 healthy subjects served as the control group .The severity of coronary artery disease in patients with coronary heart disease was evaluated by Gensini score .Plasma concentration of Ang-1 ,Ang-2 and MMP-2 was measured .Results :The concentration of plasma Ang-2 and MM P-2 in patients with acute coronary syndrome group (AMI and UAP group ) were significantly higher than control group and SAP group with significant differences ,but not Ang-1 .Ang-2 and MMP-2 levels were positively correlated with Gensini score .There were positively correlation between Ang-2 and MMP-2 levels .Conclusion :Ang-2 levels in peripheral blood are higher in patients with acute coronary syndrome .Ang-2 stimulating MM P-2 expression and reducing plaque stability might play a role .
出处 《陕西医学杂志》 CAS 2014年第3期275-278,共4页 Shaanxi Medical Journal
基金 国家自然科学基金资助项目(81273878)
关键词 冠状动脉疾病 病理生理学 血管生成素类 代谢 基质金属蛋白酶-2 代谢 Coronary disease/physiopathology Angiopoietins/metabolism Matrix metalloproteinase-2/metabolism
  • 相关文献

参考文献11

  • 1Liew G, Campbell S, Klein R, etal. Ten-year longitudi- nal changes in retinal microvascular lesions: the athero- sclerosis risk in communities study[J]. Ophthalmology, 2011, 118(8): 1612-1618.
  • 2Toutouzas K, Synetos A, Nikolaou C, etal. Matrix met- alloproteinases and vulnerable atheromatous plaque [J]. Curr Top Med Chem, 2012, 12(10): 1166-1180.
  • 3刘军,陈新军,吴小花.血浆基质金属蛋白酶-2、9与脑梗死的相关性研究[J].陕西医学杂志,2010,39(10):1352-1353. 被引量:8
  • 4Nykannen AI, Krebs R. Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis [J]. Circulation, 2003, 107(9) : 1308-1314.
  • 5Nykanen AI, Pajusola K, Krebs R, et al. Common pro- tective and diverse smooth muscle cell effects of AAV- mediated angiopoietin-1 and -2 expression in rat cardiac allograft vaseulopathy [J]. Cire Res, 2006, 98 (11): 1373-1380.
  • 6Ahmed A, Fujisawa T, Niu XL, et al. Angiopoietin-2 confers atheroprotection in apoE^-/- mice by inhibiting LDL oxidation via nitric oxide [J]. Circ Res, 2009, 104 (12) .. 1333-1336.
  • 7Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, an- giopoietin-2, angiopoietin receptor tie-2, and vascular en- dothelial growth factor levels in acute coronary syndromes [J]. Circulation, 2004, 110(16):2355-2360.
  • 8郑安红,张维东.血管生成素-2与肿瘤血管生成的研究进展[J].国际肿瘤学杂志,2012,39(5):352-355. 被引量:4
  • 9Hu B, Jarzynka MJ, Guo P, et al. Angiopoietin 2 in- duces glioma cell invasion by stimulating matrix metallo- protease 2 expression through the alphavbetal integrin and focal adhesion kinase signaling pathway [J]. Cancer Res, 2006, 66(2): 775-783.
  • 10陈新军,刘洁琳,温绍君.血浆基质金属蛋白酶-2,9与CABG患者心功能NYHA分级的相关性研究[J].陕西医学杂志,2012,41(10):1354-1355. 被引量:5

二级参考文献13

  • 1茹小娟,王文志.社区人群脑卒中危险因素干预研究进展[J].中国慢性病预防与控制,2006,14(2):133-135. 被引量:25
  • 2Fatar M, Stroick M, Griebe M, et al. Matrix metalloproteinases in cerebrovascular diseases [J]. Cerebrovasc Dis, 2005, 20:141-148.
  • 3Park KP, Rosell A, Foerch C, et al. Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats [J]. Stroke, 2009,40 : 2836-2842.
  • 4Wang G, Guo Q, Hossain M, et al. Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice [J]. Brain Res, 2009,1294: 183-192.
  • 5Nagel S, Su Y, Horstmann S, et al. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat:effects on BBB breakdown and MMP expression in the acute and subacute phase [J]. Clin Chem,2010,56:21-33.
  • 6Saenger AK, Christenson RH. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment [J]. Brain Res, 2008,188 : 198-206.
  • 7Agostoni P, Banff C. Matrix metalloproteinase and heart failure., is it time to move from research to clinical labora- tories? [J].Eur Heart J,2007,28:659-660.
  • 8Deardorff R, Spinale FG. Cytokines and matrix metallo- proteinases as potential biomarkers in chronic heart fail- ure[J]. Biomark Meal,2009,3(5) :513- 523.
  • 9Kupai K ,Szucs G, Cseh S, et al. Matrix metalloproteinase activity assays: Importance of zymography[J]. J Pharma- col Toxicol Methods ,2010,61 (2) : 205-209.
  • 10Kelly D,Khan SQ,Thompson M,et al. Plasma tissue in- hibitor of metalloproteinase-1 and matrix metalloprotein- ase-9:novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction[J]. Eur Heart J, 2008,29: 2116-2124.

共引文献14

同被引文献84

  • 1张灵利,何艳杰,李红.幽门螺旋杆菌相关胃病不同中医证候患者胃黏膜MMP-2、TIMP-1的表达及临床意义[J].陕西中医,2020,41(3):353-356. 被引量:12
  • 2沈绍功,姚金城.中医心病之心绞痛诊断与疗效标准[J].中国医药学报,2004,19(10):581-583. 被引量:136
  • 3Naghavi M, Libby P, Falk E,et al. From vulnerable plaque tovulnerable patient : a call for new definitions and risk assessmentstrategies ; Part I[ J] . Circulation , 2003 ,108( 14) : 1664-1672.
  • 4Ma R, Zhang W, Wang T, et al. Pentraxin 3, long expression inmononuclear cells of patients with acute coronary syndrome : Correla-tion with C-reactive protein and matrix metalloproteinase-9 levels[ J].J Int Med Res, 2014,42(3) :677-683.
  • 5Chandrasekar B, Mummidi S, Mahimainathan L, et al. Interleu-kin-18-induced human coronary artery smooth muscle cell migra-tion is dependent on NF-kappaB- and AP-1 -mediated matrix met-alloproteinase-9 expression and is inhibited by atorvastatin [ J ].J Biol Chem,2006,281(22) : 15099-15109.
  • 6礼希噥,刘闺男.非ST段抬高型心肌梗死患者GRACE危险积分与冠状动脉狭窄程度相关性分析[J] .中国循环杂志,2014,29(zl) :52-53.
  • 7Schmidt R,Btiltmann A,lingerer M,et al. Extracellular matrixmetalloproteinase inducer regulates matrix metalloproteinase activi-ty in cardiovascular cells : implications in acute myocardial infarc-tion [J]. Circulation, 2006,113(6) :834-841.
  • 8Holven KB, Halvorsen B, Bjerkeli V, et al. Impaired inhibitoryeffect of interleukin-10 on the balance between matrix metallopro-teinase-9 and its inhibitor in mononuclear cells from hyperhomo-cysteinemic subjects[ J]. Stroke, 2006,37(7) :1731-1736.
  • 9Mori M,Massaro A,Calderone V, et al. Discovery of a New Class ofPotent MMP Inhibitors by Structure-Based Optimization of the Aryl-sulfonamide Scaffold[J]. ACS Med Chem Lett, 2013,4(6) :565-569.
  • 10Guo C,Zhang S,Zhang J, et al. Correlation between the severityof coronary artery lesions and levels of estrogen, hs-CRP andMMP-9[J]. Exp Ther Med, 2014,7(5) :1177-1180.

引证文献9

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部